Calcium signaling dysfunction in schizophrenia: a unifying approach

Akbarian, 1996, Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients, Arch. Gen. Psychiatry, 53, 425, 10.1001/archpsyc.1996.01830050061010 Akira, 2002, Schizophrenia: diverse approaches to complex disease, Science, 296, 692, 10.1126/science.1070532 Albert, 2002, Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia, Arch. Gen. Psychiatry, 59, 705, 10.1001/archpsyc.59.8.705 Alexander, 1981, Calcium and magnesium: relationship to schizophrenia and neuroleptic-induced extrapyramidal symptoms, 247 Andreasen, 1997, Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients, Lancet, 349, 1730, 10.1016/S0140-6736(96)08258-X Arnold, 1999, Neurodevelopmental abnormalities in schizophrenia: insights from neuropathology, Dev. Psychopathol., 11, 439, 10.1017/S095457949900214X Bacic, 1991, Dopaminergic receptors linked to adenylate cyclase in human cerebromicrovascular endothelium, J. Neurochem., 57, 1774, 10.1111/j.1471-4159.1991.tb06380.x Bartzokis, 2002, Schizophrenia: breakdown in the well-regulated lifelong process of brain development and maturation, Neuropsychopharmacology, 27, 672, 10.1016/S0893-133X(02)00364-0 Batuecas, 1998, Effects of chronic nimodipine on working memory of old rats in relation to defects in synaptosomal calcium homeostasis, Eur. J. Pharmacol., 350, 141, 10.1016/S0014-2999(98)00250-7 Beasley, 2001, Glycogen synthase kinase-3β immunoreactivity is reduced in the prefrontal cortex in schizophrenia, Neurosci. Lett., 302, 117, 10.1016/S0304-3940(01)01688-3 Bellomo, 1987, Oxidative stress injury studied in isolated intact cells, Mol. Toxicol., 1, 281 Benes, 1986, Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics, Arch. Gen. Psychiatry, 43, 31, 10.1001/archpsyc.1986.01800010033004 Benes, 1991, Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients, Arch. Gen. Psychiatry, 48, 996, 10.1001/archpsyc.1991.01810350036005 Benes, 1998, A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives, Biol. Psychiatry, 44, 88, 10.1016/S0006-3223(98)00138-3 Benes, 2001, GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder, Neuropsychopharmacology, 25, 1, 10.1016/S0893-133X(01)00225-1 Benfenati, 1992, Synaptic vesicle-associated Ca2+/calmodulin-dependent protein kinase II is a binding protein for synapsin I, Nature, 359, 417, 10.1038/359417a0 Benowitz, 1997, GAP-43: an intrinsic determinant of neuronal development and plasticity, Trends Neurosci., 20, 84, 10.1016/S0166-2236(96)10072-2 Ben-Shachar, 2002, Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine, J. Neurochem., 83, 1241, 10.1046/j.1471-4159.2002.01263.x Berger, 2002, Implications of lipid biology for the pathogenesis of schizophrenia, Aust. NZ J. Psychiatry, 36, 355, 10.1046/j.1440-1614.2001.01021.x Bernstein, 2001, Increased number of nitric oxide synthase immunoreactive Purkinje cells and dentate nucleus neurons in schizophrenia, J. Neurocytol., 30, 661, 10.1023/A:1016520932139 Bernstein, 2002, Hippocampal expression of the calcium sensor protein visinin-like protein-1 in schizophrenia, Neuroreport, 13, 393, 10.1097/00001756-200203250-00006 Bersani, 2000, Data and hypotheses on the role of nerve growth factor and other neurotrophins in psychiatric disorders, Med. Hypotheses, 55, 199, 10.1054/mehy.1999.1044 Binda, 2002, D2 and D3 dopamine receptor cell surface localization mediated by interaction with protein 4.1N, Mol. Pharmacol., 62, 507, 10.1124/mol.62.3.507 Bird, 2000, The effect of calcium ionophore A23187 on neurites from embryonic mouse spinal cord explants in culture, J. Electron. Microsc. (Tokyo), 49, 379, 10.1093/oxfordjournals.jmicro.a023818 Birnbaum, 2001, The intracellular signaling mechanisms mediating stress-induced prefrontal cortex dysfunction in rats, Am. Soc. Neurosci. Abs., 27, 1404 Blennow, 1999, The growth-associated protein GAP-43 is increased in the hippocampus and in the gyrus cinguli in schizophrenia, J. Mol. Neurosci., 13, 101, 10.1385/JMN:13:1-2:101 Bofill-Cardona, 2000, Binding of calmodulin to the D2-dopamine receptor reduces receptor signaling by arresting the G protein activation switch, J. Biol. Chem., 275, 32672, 10.1074/jbc.M002780200 Boxer, 1999, FGF-2 potentiates Ca(2+)-dependent inactivation of NMDA receptor currents in hippocampal neurons, J. Neurophysiol., 82, 3367, 10.1152/jn.1999.82.6.3367 Brandon, 2000, GABAa receptor phosphorylation and functional modulation in cortical neurons by a protein kinase C-dependent pathway, J. Biol. Chem., 275, 38856, 10.1074/jbc.M004910200 Braunewell, 1999, Intracellular neuronal calcium sensor proteins: a family of EF-hand calcium-binding proteins in search of a function, Cell. Tissue Res., 295, 1, 10.1007/s004410051207 Broadbelt, 2002, Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex, Schizophr. Res., 58, 75, 10.1016/S0920-9964(02)00201-3 Browning, 1993, Significant reductions in synapsin but not synaptophysin specific activity in the brains of some schizophrenics, Biol. Psychiatry, 34, 529, 10.1016/0006-3223(93)90195-J Cadet, 1994, Free radical mechanisms in schizophrenia and tardive dyskinesia, Neurosci. Biobehav. Rev., 18, 457, 10.1016/0149-7634(94)90001-9 Calabresi, 2001, Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine, J. Neurosci., 21, 5110, 10.1523/JNEUROSCI.21-14-05110.2001 Carlsson, 2001, Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence, Annu. Rev. Pharmacol. Toxicol., 41, 237, 10.1146/annurev.pharmtox.41.1.237 Castner, 1999, Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys, Neuropsychopharmacology, 20, 10, 10.1016/S0893-133X(98)00050-5 Cepeda, 1998, Dopamine and N-methyl-d-aspartate receptor interactions in the neostriatum, Dev. Neurosci., 20, 1, 10.1159/000017294 Chen, 2001, Arachidonic acid-induced H+ and Ca2+ increases in both the cytoplasm and nucleoplasm of rat cerebellar granule cells, J. Physiol., 537, 497, 10.1111/j.1469-7793.2001.00497.x Cheng, 1994, NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults, Brain Res., 640, 56, 10.1016/0006-8993(94)91857-0 Choi, 2001, Sustained signaling by phospholipase C-gamma mediates nerve growth factor-triggered gene expression, Mol. Cell. Biol., 21, 2695, 10.1128/MCB.21.8.2695-2705.2001 Climent, 2000, Astrocytes in culture express the full-length Trk-B receptor and respond to brain derived neurotrophic factor by changing intracellular calcium levels: effect of ethanol exposure in rats, Neurosci. Lett., 7, 53, 10.1016/S0304-3940(00)01207-6 Copolov, 2000, Biological markers and schizophrenia, Aust. NZ J. Psychiatry, 34, S108, 10.1046/j.1440-1614.2000.00778.x Costa, 2001, Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability, Neurobiol. Dis., 8, 723, 10.1006/nbdi.2001.0436 Daniel, 1989, The effect of apomorphine on regional cerebral blood flow in schizophrenia, J. Neuropsychiatry Clin. Neurosci., 1, 377, 10.1176/jnp.1.4.377 Daniel, 1991, The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia, J. Neurosci., 11, 1907, 10.1523/JNEUROSCI.11-07-01907.1991 D’Arcangelo, 1999, Reelin is a ligand for lipoprotein receptors, Neuron, 24, 471, 10.1016/S0896-6273(00)80860-0 Das, 1995, Elevated platelet calcium mobilization and nitric oxide synthase activity may reflect abnormalities in schizophrenic brain, Biochem. Biophys. Res. Commun., 212, 375, 10.1006/bbrc.1995.1980 Dean, 1997, Changes in protein kinase C and adenylate cyclase in the temporal lobe from subjects with schizophrenia, J. Neural Transm., 104, 1371, 10.1007/BF01294738 Desrues, 1993, Effect of dopamine on adenylate cyclase activity, polyphosphoinositide metabolism and cytosolic calcium concentrations in frog pituitary melanotrophs, J. Endocrinol., 136, 421, 10.1677/joe.0.1360421 Donato, 2001, S100: a multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles, Int. J. Biochem. Cell Biol., 33, 637, 10.1016/S1357-2725(01)00046-2 Durany, 2001, Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses, Schizophr. Res., 52, 79, 10.1016/S0920-9964(00)00084-0 Eastwood, 1998, Hippocampal and cortical growth-associated protein-43 messenger RNA in schizophrenia, Neuroscience, 86, 437, 10.1016/S0306-4522(98)00040-2 Eastwood, 2000, Synaptophysin gene expression in schizophrenia. Investigation of synaptic pathology in the cerebral cortex, Br. J. Psychiatry, 176, 236, 10.1192/bjp.176.3.236 Elvevag, 2000, Cognitive impairment in schizophrenia is the core of the disorder, Crit. Rev. Neurobiol., 14, 1, 10.1615/CritRevNeurobiol.v14.i1.10 Emilien, 1999, Dopamine receptors and schizophrenia: contribution of molecular genetics and clinical neuropsychology, Int. J. Neuropsychopharmacol., 2, 197, 10.1017/S1461145799001479 Emilien, 1999, Dopamine receptors—physiological understanding to therapeutic intervention potential, Pharmacol. Ther., 84, 133, 10.1016/S0163-7258(99)00029-7 Ermak, 2002, Calcium and oxidative stress: from cell signaling to cell death, Mol. Immunol., 38, 713, 10.1016/S0161-5890(01)00108-0 Eyles, 2002, Neuronal calcium-binding proteins and schizophrenia, Schizophr. Res., 57, 27, 10.1016/S0920-9964(01)00299-7 Falkai, 1986, Cell loss in the hippocampus of schizophrenics, Eur. Arch. Psychiatry Neurol. Sci., 236, 154, 10.1007/BF00380943 Fatemi, 2001, Altered levels of Reelin and its isoforms in schizophrenia and mood disorders, Neuroreport, 12, 3209, 10.1097/00001756-200110290-00014 Fenton, 2000, Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia, Biol. Psychiatry, 47, 8, 10.1016/S0006-3223(99)00092-X Foong, 2000, In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging, J. Neurol. Neurosurg. Psychiatry, 68, 70, 10.1136/jnnp.68.1.70 Fujiwara, 1987, D2-dopamine receptor-mediated inhibition of intracellular Ca2+ mobilization and release of acetylcholine from guinea-pig neostriatal slices, Br. J. Pharmacol., 91, 287, 10.1111/j.1476-5381.1987.tb10283.x Gabriel, 1997, Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia, Arch. Gen. Psychiatry, 54, 559, 10.1001/archpsyc.1997.01830180077010 Gao, 2001, Presynaptic regulation of recurrent excitation by D1 receptors in prefrontal circuits, Proc. Natl. Acad. Sci. USA, 98, 295, 10.1073/pnas.011524298 Gattaz, 2000, Decreased S100-beta protein in schizophrenia: preliminary evidence, Schizophr. Res., 43, 91, 10.1016/S0920-9964(99)00146-2 Gerendasy, 1999, Homeostatic tuning of Ca2+ signal transduction by members of the calpacitin protein family, J. Neurosci. Res., 58, 107, 10.1002/(SICI)1097-4547(19991001)58:1<107::AID-JNR11>3.0.CO;2-G Gerfen, 1992, The neostriatal mosaic: multiple levels of compartmental organization, J. Neural. Transm. Suppl., 36, 43 Gibson, 2001, Oxidative stress increases internal calcium stores and reduces a key mitochondrial enzyme, Biochim. Biophys. Acta, 1586, 177, 10.1016/S0925-4439(01)00091-6 Gnegy, 1994, Repeated haloperidol increases both calmodulin and a calmodulin-binding protein in rat striatum, Mol. Brain Res., 27, 195, 10.1016/0169-328X(94)90001-9 Goff, 1997, Glutamate in schizophrenia: clinical and research implications, Schizophr. Res., 27, 157, 10.1016/S0920-9964(97)00079-0 Goldman-Rakic, 1994, Working memory dysfunction in schizophrenia, J. Neuropsychiatry Clin. Neurosci., 6, 348, 10.1176/jnp.6.4.348 Gomperts, 2002 Goncalves, 2001, Ca2+ sensitivity of synaptic vesicle dopamine, gamma-aminobutyric acid, and glutamate transport systems, Neurochem. Res., 26, 75, 10.1023/A:1007684716964 Goodman, 2000, Meeting report: ‘molecular neurobiological mechanisms in schizophrenia: seeking a synthesis’, Biol. Psychiatry, 48, 173, 10.1016/S0006-3223(00)00904-5 Grebb, 1986, A negative, double-blind, placebo-controlled, clinical trial of verapamil in chronic schizophrenia, Biol. Psychiatry, 21, 691, 10.1016/0006-3223(86)90132-0 Greengard, 1994, Synapsin I, an actin-binding protein regulating synaptic vesicle traffic in the nerve terminal, Adv. Second Messenger Phosphoprotein Res., 29, 31, 10.1016/S1040-7952(06)80005-4 Greengard, 1998, The DARPP-32/protein phosphatase-1 cascade: a model for signal integration, Brain Res. Rev., 26, 274, 10.1016/S0165-0173(97)00057-X Greiner, 1975, Human brain contents of calcium, copper, magnesium, and zinc in some neurological pathologies, Clin. Chim. Acta, 64, 211, 10.1016/0009-8981(75)90203-X Gerendasy, 1999, Homeostatic tuning of Ca2+ signal transduction by members of the calpacitin protein family, J. Neurosci. Res., 58, 107, 10.1002/(SICI)1097-4547(19991001)58:1<107::AID-JNR11>3.0.CO;2-G Hakak, 2001, Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia, Proc. Natl. Acad. Sci. USA, 98, 4746, 10.1073/pnas.081071198 Harrison, 1999, The neuropathology of schizophrenia. A critical review of the data and their interpretation, Brain, 122, 593, 10.1093/brain/122.4.593 Hartigan, 1999, Transient increases in intracellular calcium result in prolonged site-selective increases in Tau phosphorylation through a glycogen synthase kinase 3β-dependent pathway, J. Biol. Chem., 274, 21395, 10.1074/jbc.274.30.21395 Heizmann, 2002, S100 proteins: structure, functions and pathology, Front. Biosci., 7, d1356, 10.2741/heizmann Hemby, 2002, Gene expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex, Arch. Gen. Psychiatry, 59, 631, 10.1001/archpsyc.59.7.631 Hernandez-Lopez, 2000, D2 dopamine receptors in striatal medium spiny neurons reduce L-type Ca2+ currents and excitability via a novel PLCβ1-IP3-calcineurin-signaling cascade, J. Neurosci., 20, 8987, 10.1523/JNEUROSCI.20-24-08987.2000 Hirai, 1999, Inhibiting neuronal migration by blocking NMDA receptors in the embryonic rat cerebral cortex: a tissue culture study, Dev. Brain Res., 114, 63, 10.1016/S0165-3806(99)00019-X Honer, 1999, Synaptic and plasticity-associated proteins in anterior frontal cortex in severe mental illness, Neuroscience, 91, 1247, 10.1016/S0306-4522(98)00679-4 Horrobin, 1996, Schizophrenia as a membrane lipid disorder which is expressed throughout the body, Prostaglandins Leukot. Essent. Fatty Acids, 55, 3, 10.1016/S0952-3278(96)90138-6 Hudson, 1999, Clinical subtyping reveals significant differences in calcium-dependent phospholipase A2 activity in schizophrenia, Biol. Psychiatry, 46, 401, 10.1016/S0006-3223(99)00010-4 Iadecola, 1993, Regulation of the cerebral microcirculation during neural activity: is nitric oxide the missing link?, Trends Neurosci., 16, 206, 10.1016/0166-2236(93)90156-G Impagnatiello, 1998, A decrease of reelin expression as a putative vulnerability factor in schizophrenia, Proc. Natl. Acad. Sci. USA, 95, 15718, 10.1073/pnas.95.26.15718 Ishii, 2001, Ca(2+) elevation evoked by membrane depolarization regulates G protein cycle via RGS proteins in the heart, Circ. Res., 89, 1045, 10.1161/hh2301.100815 Isokawa, 1998, Modulation of GABAA receptor-mediated inhibition by postsynaptic calcium in epileptic hippocampal neurons, Brain Res., 810, 241, 10.1016/S0006-8993(98)00922-6 Jarskog, 2000, Cortical Bcl-2 protein expression and apoptotic regulation in schizophrenia, Biol. Psychiatry, 48, 641, 10.1016/S0006-3223(00)00988-4 Javitt, 1991, Recent advances in the phencyclidine model of schizophrenia, Am. J. Psychiatry, 148, 1301, 10.1176/ajp.148.10.1301 Jeste, 1989, Hippocampal pathologic findings in schizophrenia. A morphometric study, Arch Gen. Psychiatry, 46, 1019, 10.1001/archpsyc.1989.01810110061009 Jimerson, 1979, CSF calcium: clinical correlates in affective illness and schizophrenia, Biol. Psychiatry, 14, 37 Jung, 2000, Targeted disruption of dopamine D92) and D93) receptor genes leads to different alterations in the expression of striatal calbindin-D(2k), Neuroscience, 97, 495, 10.1016/S0306-4522(00)00027-0 Kabbani, 2002, Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor, J. Neurosci., 22, 8476, 10.1523/JNEUROSCI.22-19-08476.2002 Kaiya, 1992, Second messenger imbalance hypothesis of schizophrenia, Prostaglandins Leukot. Essent. Fatty Acids, 46, 33, 10.1016/0952-3278(92)90056-O Kaneko, 1992, Effect of haloperidol on cyclic AMP and inositol trisphosphate in rat striatum in vivo, Prostaglandins Leukot. Essent. Fatty Acids, 46, 53, 10.1016/0952-3278(92)90059-R Kantor, 1999, Enhanced amphetamine- and K+-mediated dopamine release in rat striatum after repeated amphetamine: differential requirements for Ca2+- and calmodulin-dependent phosphorylation and synaptic vesicles, J. Neurosci., 19, 3801, 10.1523/JNEUROSCI.19-10-03801.1999 Kardos, 1994, Role of GABAB receptors in intracellular Ca2+ homeostasis and possible interaction between GABAA and GABAB receptors in regulation of transmitter release in cerebellar granule neurons, J. Neurosci. Res., 39, 646, 10.1002/jnr.490390604 Karson, 1996, Nitric oxide synthase (NOS) in schizophrenia: increases in cerebellar vermis, Mol. Chem. Neuropathol., 27, 275, 10.1007/BF02815109 Kassack, 2002, Functional screening of G protein-coupled receptors by measuring intracellular calcium with a fluorescence microplate reader, J. Biomol. Screen, 7, 233 Khodorova, 1994, A dual effect of arachidonic acid on Ca2+ transport systems in lymphocytes, FEBS Lett., 353, 167, 10.1016/0014-5793(94)01029-3 Kinoshita, 2001, Binding of Gα(o) N terminus is responsible for the voltage-resistant inhibition of α(1A) (P/Q-type, Ca(v)2.1) Ca(2+) channels, J. Biol. Chem., 276, 28731, 10.1074/jbc.M104806200 Knable, 1997, Dopamine, the prefrontal cortex and schizophrenia, J. Psychopharmacol., 11, 123, 10.1177/026988119701100205 Knable, 2001, Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium, Brain Res. Bull., 55, 651, 10.1016/S0361-9230(01)00521-4 Koh, 2003, Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients, Proc. Natl. Acad. Sci. USA, 100, 313, 10.1073/pnas.232693499 Koh, 2003, Upregulation of the D1 dopamine receptor-interacting protein, calcyon, in patients with schizophrenia, Arch. Gen. Psychiatry, 60, 311, 10.1001/archpsyc.60.3.311 Kornhuber, 1994, Iron, copper, zinc, magnesium, and calcium in postmortem brain tissue from schizophrenic patients, Biol. Psychiatry, 36, 31, 10.1016/0006-3223(94)90059-0 Kotecha, 2002, A D2 class dopamine receptor transactivates a receptor tyrosine kinase to inhibit NMDA receptor transmission, Neuron, 35, 1111, 10.1016/S0896-6273(02)00859-0 Kozlovsky, 2002, GSK-3 and the neurodevelopmental hypothesis of schizophrenia, Eur. Neuropsychopharmacol., 12, 13, 10.1016/S0924-977X(01)00131-6 Krauss, 2001 Krupp, 1999, Interactions of calmodulin and alpha-actinin with the NR1 subunit modulate Ca2+-dependent inactivation of NMDA receptors, J. Neurosci., 19, 1165, 10.1523/JNEUROSCI.19-04-01165.1999 Krupp, 2002, Calcineurin acts via the C-terminus of NR2A to modulate desensitization of NMDA receptors, Neuropharmacology, 42, 593, 10.1016/S0028-3908(02)00031-X Kuhl, 2000, The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape, Trends Genet., 16, 279, 10.1016/S0168-9525(00)02028-X Kuperberg, 2000, Schizophrenia and cognitive function, Curr. Opin. Neurobiol., 10, 205, 10.1016/S0959-4388(00)00068-4 Landen, 1999, Reduction of the small synaptic vesicle protein synaptophysin but not the large dense core chromogranins in the left thalamus of subjects with schizophrenia, Biol. Psychiatry, 46, 1698, 10.1016/S0006-3223(99)00160-2 Landen, 2002, Reduction of the synaptophysin level but normal levels of glycerophospholipids in the gyrus cinguli in schizophrenia, Schizophr. Res., 55, 83, 10.1016/S0920-9964(01)00197-9 Lara, 2001, Increased serum S100β protein in schizophrenia: a study in medication-free patients, J. Psychiatr. Res., 35, 11, 10.1016/S0022-3956(01)00003-6 Laruelle, 1998, Imaging dopamine transmission in schizophrenia. A review and meta-analysis, Q. J. Nucl. Med., 42, 211 Lautermilch, 2000, Regulation of calcineurin by growth cone calcium waves controls neurite extension, J. Neurosci., 20, 315, 10.1523/JNEUROSCI.20-01-00315.2000 Lee, 1996, Dopamine (D2) receptor regulation of intracellular calcium and membrane capacitance changes in rat melanotrophs, J. Physiol., 495, 627, 10.1113/jphysiol.1996.sp021621 Lee, 2002, Dual regulation of NMDA receptor functions by direct protein–protein interactions with the dopamine D1 receptor, Cell, 111, 219, 10.1016/S0092-8674(02)00962-5 Lejoyeux, 1991, Could the interaction of neuroleptics with calmodulin be an ‘explanation’ of the psychotropic effects?, Encephale, 17, 11 Leonhardt, 1998, Antioxidative action of the novel calcium channel antagonist mibefradil on low-density lipoproteins, Eur. J. Clin. Pharmacol., 54, 603, 10.1007/s002280050521 Lezcano, 2000, Dual signaling regulated by calcyon, a D1 dopamine receptor interacting protein, Science, 287, 1660, 10.1126/science.287.5458.1660 Lezcano, 2001, D1/D5 dopamine receptors stimulate intracellular calcium release in primary cultures of neocortical and hippocampal neurons, J. Neurophysiol., 87, 2167, 10.1152/jn.00541.2001 Lidow, 2000, General overview of contemporary antipsychotic medications, 17 Lidow, 1998, The cerebral cortex: a case for a common site of action of antipsychotics, Trends Pharmacol. Sci., 19, 136, 10.1016/S0165-6147(98)01186-9 Lidow, 2003, D1 dopamine receptors in the mouse prefrontal cortex: immunocytochemical and cognitive neuropharmacological analyses, Synapse, 47, 101, 10.1002/syn.10143 Lin, 2001, Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A, Proc. Natl. Acad. Sci. USA, 98, 5258, 10.1073/pnas.011538198 Lin, 1999, Opposite changes in phosphoinositide-specific phospholipase C immunoreactivity in the left prefrontal and superior temporal cortex of patients with chronic schizophrenia, Biol. Psychiatry, 46, 1665, 10.1016/S0006-3223(99)00036-0 Loeber, 1999, Differences in cerebellar blood volume in schizophrenia and bipolar disorder, Schizophr. Res., 37, 81, 10.1016/S0920-9964(98)00137-6 Mahadik, 2001, Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia, Prog. Neuropsychopharmacol. Biol. Psychiatry, 25, 463, 10.1016/S0278-5846(00)00181-0 Mak, 2002, Protective effects of dihydropyridine Ca-blockers against endothelial cell oxidative injury due to combined nitric oxide and superoxide, Pharmacol. Res., 45, 27, 10.1006/phrs.2001.0903 Marta, 2002, Molecular mechanisms involved in the actions of apotransferrin upon the central nervous system: role of the cytoskeleton and of second messengers, J. Neurosci. Res., 69, 488, 10.1002/jnr.10317 Martinez-Serrano, 1996, Modulation of presynaptic calcium homeostasis by nitric oxide, Cell. Calcium, 20, 293, 10.1016/S0143-4160(96)90035-4 Mattson, 1992, Calcium as sculptor and destroyer of neural circuitry, Exp. Gerontol., 27, 29, 10.1016/0531-5565(92)90027-W Maurer, 2001, Evidence for a mitochondrial oxidative phosphorylation defect in brains from patients with schizophrenia, Schizophr. Res., 48, 125, 10.1016/S0920-9964(00)00075-X McCutchen, 2002, Modulation of neuronal calcium signaling by neurotrophic factors, Int. J. Dev. Neurosci., 20, 199, 10.1016/S0736-5748(02)00014-X McGlashan, 2000, Schizophrenia as a disorder of developmentally reduced synaptic connectivity, Arch. Gen. Psychiatry, 57, 637, 10.1001/archpsyc.57.7.637 Meyer-Lindenberg, 2002, Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia, Nat. Neurosci., 5, 267, 10.1038/nn804 Middleton, 2002, Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia, J. Neurosci., 22, 2718, 10.1523/JNEUROSCI.22-07-02718.2002 Mirnics, 2000, Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex, Neuron, 28, 53, 10.1016/S0896-6273(00)00085-4 Mirnics, 2001, Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia, Mol. Psychiatry, 6, 293, 10.1038/sj.mp.4000866 Mirotznik, 2000, G-Protein types involved in calcium channel inhibition at a presynaptic nerve terminal, J. Neurosci., 20, 7614, 10.1523/JNEUROSCI.20-20-07614.2000 Miyaoka, 1999, Increased expression of Wnt-1 in schizophrenic brains, Schizophr. Res., 38, 1, 10.1016/S0920-9964(98)00179-0 H.W. Moises, Human genome data analysis by an evolutionary method suggests a decrease in protein-synthesis rate as cause of schizophrenia and an increase as antipsychotic mechanism, ArXiv.org e-Pprint archive (2001) [http://xxx.arxiv.cornell.edu/abs/cond-mat/0110189]. Moises, 2002, The glial growth factors deficiency and synaptic destabilization hypothesis of schizophrenia, BMC Psychiatry, 2, 8, 10.1186/1471-244X-2-8 Moller, 1996, Rapid conversion of myelin-associated glycoprotein to a soluble derivative in primates, Brain Res., 741, 27, 10.1016/S0006-8993(96)00882-7 Muallem, 1999, G protein-dependent Ca2+ signaling complexes in polarized cells, Cell Calcium, 26, 173, 10.1054/ceca.1999.0077 Murakami, 2002, Phospholipase A2, J. Biochem. (Tokyo), 131, 285, 10.1093/oxfordjournals.jbchem.a003101 Nawa, 2000, Cytokine and growth factor involvement in schizophrenia—support for the developmental model, Mol. Psychiatry, 5, 594, 10.1038/sj.mp.4000730 Nelson, 1990, Mechanisms involved in activity-dependent synapse formation in mammalian central nervous system cell cultures, J. Neurobiol., 21, 138, 10.1002/neu.480210110 Neylon, 1998, Heterotrimeric Gi protein is associated with the inositol 1,4,5-trisphosphate receptor complex and modulates calcium flux, Cell Calcium, 23, 281, 10.1016/S0143-4160(98)90024-0 Nicol, 1997, Ca2+-dependent interaction with calmodulin is conserved in the synapsin family: identification of a high-affinity site, Biochemistry, 36, 11487, 10.1021/bi970709r Nikashin, 1999, Regulation of inositol-1,4,5-triphosphate receptor by G(i)-protein, Ross. Fiziol. Zh. Im. IM. Sechenova, 85, 1011 Novak, 2000, Schizophrenia: elevated mRNA for calcium-calmodulin-dependent protein kinase IIbeta in frontal cortex, Mol. Brain Res., 82, 95, 10.1016/S0169-328X(00)00188-1 Numakawa, 2002, Basic fibroblast growth factor evokes a rapid glutamate release through activation of the MAPK pathway in cultured cortical neurons, J. Biol. Chem., 277, 28861, 10.1074/jbc.M202927200 Okada, 1991, G proteins (Gi, Go) in the medial temporal lobe in schizophrenia: preliminary report of a neurochemical correlate of structural change, J. Neural Transm. Gen. Sect., 84, 147, 10.1007/BF01249119 Okda, 1994, Reduced concentrations of the alpha-subunit of GTP-binding protein Go in schizophrenic brain, J. Neural Transm. Gen. Sect., 95, 95, 10.1007/BF01276428 Olney, 1995, Glutamate receptor dysfunction and schizophrenia, Arch. Gen. Psychiatry, 52, 998, 10.1001/archpsyc.1995.03950240016004 Olney, 1999, NMDA receptor hypofunction model of schizophrenia, J. Psychiatr. Res., 33, 523, 10.1016/S0022-3956(99)00029-1 Palermo-Neto, 1997, Dopaminergic system. Dopamine receptors, Psychiatr. Clin. North Am., 20, 705, 10.1016/S0193-953X(05)70341-5 Paul Blum, 2002, The GABAergic system in schizophrenia, Int. J. Neuropsychopharmacol., 5, 159 Perrone-Bizzozero, 1993, Posttranscriptional regulation of GAP-43 gene expression in PC12 cells through protein kinase C-dependent stabilization of the mRNA, J. Cell Biol., 120, 1263, 10.1083/jcb.120.5.1263 Perrone-Bizzozero, 1996, Levels of the growth-associated protein GAP-43 are selectively increased in association cortices in schizophrenia, Proc. Natl. Acad. Sci. USA, 93, 14182, 10.1073/pnas.93.24.14182 Pinton, 2002, A role for calcium in Bcl-2 action?, Biochimie, 84, 195, 10.1016/S0300-9084(02)01373-1 Plein, 2001, The platelet as a peripheral marker in psychiatric illness, Hum. Psychopharmacol., 16, 229, 10.1002/hup.251 Pongrac, 2002, Gene expression profiling with DNA microarrays: advancing our understanding of psychiatric disorders, Neurochem. Res., 27, 1049, 10.1023/A:1020904821237 Popken, 2000, Subnucleus-specific loss of neurons in medial thalamus of schizophrenics, Proc. Natl. Acad. Sci. USA, 97, 9276, 10.1073/pnas.150243397 Popov, 1989, Influence of dopamine receptor agonists and antagonists on calmodulin translocation in different brain regions, Eur. J. Pharmacol., 172, 205, 10.1016/0922-4106(89)90050-3 Prince, 1999, Mitochondrial function is differentially altered in the basal ganglia of chronic schizophrenics, Neuropsychopharmacology, 21, 372, 10.1016/S0893-133X(99)00016-0 Prince, 2000, Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenics, Neuropsychopharmacology, 22, 284, 10.1016/S0893-133X(99)00111-6 Ramakers, 2001, The role of calcium signaling in early axonal and dendritic morphogenesis of rat cerebral cortex neurons under non-stimulated growth conditions, Dev. Brain Res., 126, 163, 10.1016/S0165-3806(00)00148-6 Rasolonjanahary, 2002, Evidence for a direct negative coupling between dopamine-D2 receptors and PLC by heterotrimeric Gi1/2 proteins in rat anterior pituitary cell membranes, Endocrinology, 143, 747, 10.1210/en.143.3.747 Redmond, 2002, Calcium regulation of dendritic growth via CaM kinase IV and CREB-mediated transcription, Neuron, 34, 999, 10.1016/S0896-6273(02)00737-7 Reynolds, 2001, Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity, Brain Res. Bull., 55, 579, 10.1016/S0361-9230(01)00526-3 Rinaldi, 2002, Effects of docosahexaenoic acid on calcium pathway in adult rat cardiomyocytes, Life Sci., 71, 993, 10.1016/S0024-3205(02)01792-7 Ripova, 1997, Phospholipids and calcium alterations in platelets of schizophrenic patients, Physiol. Res., 46, 59 Ristow, 2000, Frataxin activates mitochondrial energy conversion and oxidative phosphorylation, Proc. Natl. Acad. Sci. USA, 97, 12239, 10.1073/pnas.220403797 Rongo, 1999, CaMKII regulates the density of central glutamatergic synapses in vivo, Nature, 402, 195, 10.1038/46065 Rosenbaum, 1995, Comparison of Sernyl with other drugs, Arch. Gen. Psychiatry, 51, 651 Ross, 1997, Increased phospholipid breakdown in schizophrenia. Evidence for the involvement of a calcium-independent phospholipase A2, Arch. Gen. Psychiatry, 54, 487, 10.1001/archpsyc.1997.01830170113015 Ross, 1999, Differential alteration of phospholipase A2 activities in brain of patients with schizophrenia, Brain Res., 821, 407, 10.1016/S0006-8993(99)01123-3 Saneyoshi, 2002, The Wnt/calcium pathway activates NF-AT and promotes ventral cell fate in Xenopus embryos, Nature, 417, 295, 10.1038/417295a Sastry, 2000, Apoptosis and the nervous system, J. Neurochem., 74, 1, 10.1046/j.1471-4159.2000.0740001.x Schwartz, 1994, Bidirectional modulation of GABA-gated chloride channels by divalent cations: inhibition by Ca2+ and enhancement by Mg2+, J. Neurochem., 62, 916, 10.1046/j.1471-4159.1994.62030916.x Sczekan, 1996, Antipsychotic drugs block IP3-dependent Ca(2+)-release from rat brain microsomes, Biol. Psychiatry, 40, 497, 10.1016/0006-3223(95)00657-5 Segal, 2001, Rapid plasticity of dendritic spine: hints to possible functions?, Prog. Neurobiol., 63, 61, 10.1016/S0301-0082(00)00021-6 Selemon, 1999, The reduced neuropil hypothesis: a circuit based model of schizophrenia, Biol. Psychiatry, 45, 17, 10.1016/S0006-3223(98)00281-9 Semeraro, 1990, Peripheral vascular and neuronal effects of dopamine receptor agonists. A comparison with receptor binding studies in rat striatum, Naunyn Schmiedebergs Arch. Pharmacol., 342, 539, 10.1007/BF00169043 Sesack, 1989, Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study, J. Pharmacol. Exp. Ther., 248, 1323 Sharp, 1994, Phencyclidine induction of the hsp 70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels, Neuroscience, 62, 1079, 10.1016/0306-4522(94)90345-X Skene, 1990, GAP-43 as a ‘calmodulin sponge’ and some implications for calcium signalling in axon terminals, Neurosci. Res., 13, S112 Slemmon, 2000, Small proteins that modulate calmodulin-dependent signal transduction: effects of PEP-19, neuromodulin, and neurogranin on enzyme activation and cellular homeostasis, Mol. Neurobiol., 22, 99, 10.1385/MN:22:1-3:099 Smalheiser, 1998, Calcium-independent phospholipase A2 and schizophrenia, Arch. Gen. Psychiatry, 55, 752, 10.1001/archpsyc.55.8.752 Smythies, 1997, Oxidative reactions and schizophrenia: a review–discussion, Schizophr. Res., 24, 357, 10.1016/S0920-9964(97)00005-4 Snyder, 1998, A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor, J. Neurosci., 18, 10297, 10.1523/JNEUROSCI.18-24-10297.1998 Sobala, 2001, Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycation, Biochem. Pharmacol., 61, 373, 10.1016/S0006-2952(00)00548-7 Soria, 2002, Receptor-activated calcium signals in tangentially migrating cortical cells, Cereb. Cortex, 12, 831, 10.1093/cercor/12.8.831 Sower, 1995, Increased levels of GAP-43 protein in schizophrenic brain tissues demonstrated by a novel immunodetection method, Mol. Chem. Neuropathol., 24, 1, 10.1007/BF03160108 Sprengel, 1994, Ionotropic glutamate receptors, 213 Starkov, 2002, Regulation of hydrogen peroxide production by brain mitochondria by calcium and Bax, J. Neurochem., 83, 220, 10.1046/j.1471-4159.2002.01153.x Stefansson, 2002, Neuregulin 1 and susceptibility to schizophrenia, Am. J. Hum. Genet., 71, 877, 10.1086/342734 Strunecka, 1999, What can the investigation of phosphoinositide signaling system in platelets of schizophrenic patients tell us?, Prostaglandins Leukot. Essent. Fatty Acids, 61, 1, 10.1054/plef.1999.0063 Studzinski, 1999, Increased intracellular calcium alters myelin gene expression in the N20.1 oligodendroglial cell line, J. Neurosci. Res., 57, 633, 10.1002/(SICI)1097-4547(19990901)57:5<633::AID-JNR5>3.0.CO;2-I Sun, 1999, Gelsolin, a multifunctional actin regulatory protein, J. Biol. Chem., 274, 33179, 10.1074/jbc.274.47.33179 Tang, 2002, Muscarinic receptors mediate phospholipase C-dependent activation of protein kinase B via Ca2+, ErbB3, and phosphoinositide 3-kinase in 1321N1 astrocytoma cells, J. Biol. Chem., 277, 338, 10.1074/jbc.M108927200 Thierry, 1986, Variation in the ability of neuroleptics to block the inhibitory influence of dopaminergic neurons on the activity of cells in the rat prefrontal cortex, Brain Res. Bull., 16, 155, 10.1016/0361-9230(86)90027-4 Toescu, 1998, Apoptosis and cell death in neuronal cells: where does Ca2+ fit in?, Cell Calcium, 24, 387, 10.1016/S0143-4160(98)90062-8 Tolar, 1998, NSF function in neurotransmitter release involves rearrangement of the SNARE complex downstream of synaptic vesicle docking, J. Neurosci., 18, 10250, 10.1523/JNEUROSCI.18-24-10250.1998 Toyooka, 2002, Decreased levels of brain-derived neurotrophic factor in serum of chronic schizophrenic patients, Psychiatry Res., 110, 249, 10.1016/S0165-1781(02)00127-0 Tsai, 2002, Glutamatergic mechanisms in schizophrenia, Annu. Rev. Pharmacol. Toxicol., 42, 165, 10.1146/annurev.pharmtox.42.082701.160735 Undie, 1990, Stimulation of a dopamine D1 receptor enhances inositol phosphates formation in rat brain, J. Pharmacol. Exp. Ther., 253, 987 van Dam, 2002, N-methyl-d-aspartate-induced long-term depression is associated with a decrease in postsynaptic protein kinase C substrate phosphorylation in rat hippocampal slices, Neurosci. Lett., 320, 29, 10.1016/S0304-3940(02)00037-X Vanhauwe, 2002, Thrombin receptors activate G(o) proteins in endothelial cells to regulate intracellular calcium and cell shape changes, J. Biol. Chem., 277, 34143, 10.1074/jbc.M204477200 Vawter, 2001, Application of cDNA microarrays to examine gene expression differences in schizophrenia, Brain Res. Bull., 55, 641, 10.1016/S0361-9230(01)00522-6 Vawter, 2002, Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study, Schizophr. Res., 58, 11, 10.1016/S0920-9964(01)00377-2 Vincent, 1995, Cellular colocalization of dopamine D1 and D2 receptors in rat medial prefrontal cortex, Synapse, 19, 112, 10.1002/syn.890190207 Vreugdenhil, 1996, Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons, Proc. Natl. Acad. Sci. USA, 93, 12559, 10.1073/pnas.93.22.12559 Wang, 1997, Differential expression of D1 and D5 dopamine receptors in the fetal primate cerebral wall, Cereb. Cortex, 7, 711, 10.1093/cercor/7.8.711 Wang, 1995, Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation, Mol. Pharmacol., 48, 988 Wang, 2000, Acceleration of trophoblast differentiation by heparin-binding EGF-like growth factor is dependent on the stage-specific activation of calcium influx by ErbB receptors in developing mouse blastocysts, Development, 127, 33, 10.1242/dev.127.1.33 Warburton, 1996, Calcium dependence of sensitised dopamine release in rat nucleus accumbens following amphetamine challenge: implications for the disruption of latent inhibition, Behav. Pharmacol., 7, 119, 10.1097/00008877-199603000-00002 Webster, 2001, Synaptophysin and GAP-43 mRNA levels in the hippocampus of subjects with schizophrenia, Schizophr. Res., 49, 89, 10.1016/S0920-9964(00)00052-9 Weickert, 2001, Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia, Cereb. Cortex, 11, 136, 10.1093/cercor/11.2.136 Weinberger, 1996, Prefrontal function in schizophrenia: confounds and controversies, Phil. Trans. R. Soc. Lond. B Biol. Sci., 351, 1495, 10.1098/rstb.1996.0135 Weiss, 1982, Interaction of drugs with calmodulin. Biochemical, pharmacological and clinical implications, Biochem. Pharmacol., 31, 2217, 10.1016/0006-2952(82)90104-6 Whatley, 1996, Mitochondrial involvement in schizophrenia and other functional psychoses, Neurochem. Res., 21, 995, 10.1007/BF02532409 Wiesmann, 1999, Elevated plasma levels of S-100β protein in schizophrenic patients, Biol. Psychiatry, 45, 1508, 10.1016/S0006-3223(98)00217-0 Williams, 1995, Modulation of memory fields by dopamine D1 receptors in prefrontal cortex, Nature, 376, 572, 10.1038/376572a0 Xing, 2002, Decreased calcium-dependent constitutive nitric oxide synthase (cNOS) activity in prefrontal cortex in schizophrenia and depression, Schizophr. Res., 58, 21, 10.1016/S0920-9964(01)00388-7 Xu, 1999, RGS proteins determine signaling specificity of Gq-coupled receptors, J. Biol. Chem., 274, 3549, 10.1074/jbc.274.6.3549 Yang, 1998, Isotype-specific G protein abnormalities in the left superior temporal cortex and limbic structures of patients with chronic schizophrenia, Biol. Psychiatry, 43, 12, 10.1016/S0006-3223(97)80250-8 Yang, 1999, Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex, Neuropsychopharmacology, 21, 161, 10.1016/S0893-133X(98)00112-2 Yao, 2001, Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications, CNS Drugs, 15, 287, 10.2165/00023210-200115040-00004 Yarlagadda, 2002, Role of calcium regulation in pathophysiology model of schizophrenia and possible interventions, Med. Hypotheses, 58, 182, 10.1054/mehy.2001.1511 Yesavage, 1978, Acute phencyclidine (PCP) intoxication: psychopathology and prognosis, J. Clin. Psychiatry, 39, 664 Yin, 2002, Ca(2+)-regulated, neurosecretory granule channel involved in release from neurohypophysial terminals, J. Physiol., 539, 409 Zhou, 2001, Interference with calcium-dependent mitochondrial bioenergetics in cardiac myocytes isolated from doxorubicin-treated rats, Toxicol. Appl. Pharmacol., 175, 60, 10.1006/taap.2001.9230